Breast Cancer Charity-funded

Breast Cancer Now

Research funded by Breast Cancer Now

Funded awards
410
Published funding
£26.1M
Active funded awards
0

Amounts are published for 162 of 410 funded awards — most Breast Cancer Now grants do not disclose funding.

Search funded awards from Breast Cancer Now →

Breast Cancer Now funds most in Cancer — 326 grants (80%). Its largest recipient is King's College London, with 33 grants.

Funded Awards by Year

View data table
YearFunded awards
200623
200731
200851
200934
201025
201138
201231
201337
201433
201534
201622
201716
201826
20198
20201

Grants

Personalising breast cancer treatment through integrative bioinformaticsUniversity of EdinburghBCN£5.0M2017Completed
Generations StudyInstitute of Cancer ResearchBCN£975K2011Completed
To assess the activation of HER2 and other HER (ErbB) receptors by Förster Resonance Energy Transfer (FRET) to determine mechanisms of sensitivity and resistance to Herceptin (Trastuzumab) and other targeted therapies in breast cancer.University of OxfordBCN£920K2008Completed
To predict and control cell response to cancer treatment by manipulating p53 isoform expression in relation to the breast cancer subtypeUniversity of DundeeBCN£554K2012Completed
Resistance mechanisms during prolonged antihormonesCardiff UniversityBCN£524K2010Completed
Defining the Microenvironment Which Enables Successful Regulatory T Cell-Targeted Immunotherapy of Breast CancerCardiff UniversityBCN£230K2020Completed
BIG 3.07 DCIS boost trialUniversity of EdinburghBCNNot disclosed2018Completed
Bosutinib effects in pre-metastatic niche formation and lung metastasis in breast cancerChampalimaud FoundationBCNNot disclosed2018Completed
Breast Cancer Specific Unconventional killer T-cellsCardiff University School of MedicineBCNNot disclosed2018Completed
CAR T-cell mediated co-targeting of MUC1 and HER2 to achieve precision immunotherapy of breast cancerKing's College LondonBCNNot disclosed2019Completed
Characterisation of the protease CTSS as a novel therapeutic target in TNBCQueen's University BelfastBCNNot disclosed2018Completed
Characterising a novel TBX2-KDM1A transcriptional repression complex with roles in senescence-bypass and breast cancer prognosis.Queen's University BelfastBCNNot disclosed2017Completed
Characterising the role of RET in breast cancer brain metastasis as a facilitator of colonisation and a novel targeted therapyRoyal College of Surgeons in IrelandBCNNot disclosed2019Completed
Characterizing the in vivo functions of P-Rex1 and Rac1b in breastUniversity of ManchesterBCNNot disclosed2017Completed
Co-evolution of the tumour microenvironment and cancer resistance to endocrine therapyInstitute of Cancer ResearchBCNNot disclosed2017Completed
Defining ‘best use’ of bosutinib in breast cancerUniversity of EdinburghBCNNot disclosed2017Completed
Defining the immunopeptidome of extracellular vesicles released by breast cancer cells.University of St AndrewsBCNNot disclosed2019Completed
Determining the role of the epigenetic reader bromodomain protein 3 in invasive lobular carcinomaRoyal College of Surgeons in IrelandBCNNot disclosed2017Completed
Developing strategies for treatment of breast cancer patients following progression on CDK4/6 inhibitorsImperial College LondonBCNNot disclosed2018Completed
Development and feasibility of a communication training package for therapeutic radiographers to manage emotional talk with breast cancer patients in treatmentUniversity of St AndrewsBCNNot disclosed2018Completed

Page 1 of 3